Literature DB >> 9509795

Developing information materials to present the findings of technology assessments to consumers. The experience of the NHS Centre for Reviews and Dissemination.

V A Entwistle1, I S Watt, H Davis, R Dickson, D Pickard, J Rosser.   

Abstract

We discuss some of the issues that have arisen during the development and introduction into practice of information materials for health professionals and patients that aim to promote clinical effectiveness and informed patient participation in clinical decision making.

Entities:  

Mesh：

Year:  1998        PMID： 9509795     DOI： 10.1017/s0266462300010527

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN： 0266-4623            Impact factor:   2.188


  20 in total

Review 1.  Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.

Authors:  S H Woolf; R Grol; A Hutchinson; M Eccles; J Grimshaw
Journal:  BMJ       Date:  1999-02-20

Review 2.  The potential contribution of decision aids to screening programmes.

Authors:  V Entwistle
Journal:  Health Expect       Date:  2001-06       Impact factor: 3.377

3.  The importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countries.

Authors:  Snezana Bosnjak
Journal:  Support Care Cancer       Date:  2003-10-15       Impact factor: 3.603

4.  Evaluating interventions aimed at promoting information utilization in organizations and systems.

Authors:  Damien Contandriopoulos; Astrid Brousselle; Nonvignon Marius Kêdoté
Journal:  Healthc Policy       Date:  2008-08

5.  Evidence based patient information. is important, so there needs to be a national strategy to ensure it.

Authors:  A Coulter
Journal:  BMJ       Date:  1998-07-25

6.  Sharing decisions with patients: is the information good enough?

Authors:  A Coulter; V Entwistle; D Gilbert
Journal:  BMJ       Date:  1999-01-30

7.  Involving patients in HTA activities at local level: a study protocol based on the collaboration between researchers and knowledge users.

Authors:  Marie-Pierre Gagnon; Johanne Gagnon; Michèle St-Pierre; François-Pierre Gauvin; Florence Piron; Marc Rhainds; Martin Coulombe; Dolores Lepage-Savary; Marie Desmartis; Mylène Tantchou Dipankui; France Légaré
Journal:  BMC Health Serv Res       Date:  2012-01-16       Impact factor: 2.655

8.  The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment.

Authors:  Andrew Lloyd; Emma McIntosh; Martin Price
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

9.  Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.

Authors:  Sharon K McCann; Marion K Campbell; Vikki A Entwistle
Journal:  Trials       Date:  2010-03-22       Impact factor: 2.279

10.  Introducing the patient's perspective in hospital health technology assessment (HTA): the views of HTA producers, hospital managers and patients.

Authors:  Marie-Pierre Gagnon; Marie Desmartis; Johanne Gagnon; Michèle St-Pierre; François-Pierre Gauvin; Marc Rhainds; Dolorès Lepage-Savary; Martin Coulombe; Mylène Tantchou Dipankui; France Légaré
Journal:  Health Expect       Date:  2012-10-10       Impact factor: 3.377
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.